NewAmsterdam Pharma Company N.V.

NasdaqGM:NAMS Stock Report

Market Cap: US$1.6b

NewAmsterdam Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:NAMS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Sep 24BuyUS$17,333Juliette AudetIndividual1,104US$15.70
20 Aug 24BuyUS$81,350Michael DavidsonIndividual5,000US$16.27
20 Jun 24BuyUS$86,309Michael DavidsonIndividual5,000US$17.26
26 Mar 24BuyUS$181,224Frazier Life Sciences Management, LPCompany8,429US$21.50
13 Feb 24BuyUS$95,000Louis LangeIndividual5,000US$19.00

Insider Trading Volume

Insider Buying: NAMS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NAMS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,103,4261.23%
Private Companies2,500,7072.78%
Hedge Funds8,024,5658.91%
General Public9,665,88710.7%
Institutions26,124,45529%
VC/PE Firms42,596,31747.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.3%.

Top Shareholders

Top 25 shareholders own 84.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.6%
Frazier Life Sciences Management, LP
12,226,943US$222.8m0%9.1%
13.1%
Forbion Capital Partners B.V.
11,831,461US$215.6m0%35.78%
11.6%
Bain Capital Life Sciences Investors, LLC
10,473,913US$190.8m0%19.3%
8.96%
RA Capital Management, L.P.
8,064,000US$146.9m2.54%1.65%
8.91%
Viking Global Investors LP
8,024,565US$146.2m0%0.54%
4.51%
The Morningside Group Limited
4,060,923US$74.0m0%17.01%
3.19%
Medicxi Ventures (UK) LLP
2,869,565US$52.3m0%9.94%
2.78%
Forbion International Management B.V.
2,498,438US$45.5m0%no data
2.56%
Cormorant Asset Management, LP
2,300,000US$41.9m53.3%2.06%
1.7%
Adage Capital Management, L.P.
1,530,000US$27.9m-16.1%0.05%
1.69%
BVF Partners L.P.
1,521,948US$27.7m0%0.69%
1.29%
Millennium Management LLC
1,165,429US$21.2m23%0.02%
1.13%
Janus Henderson Group plc
1,019,957US$18.6m60.3%0.01%
1.11%
Polar Capital Holdings Plc
1,002,586US$18.3m-20%0.07%
1.04%
Jennison Associates LLC
937,163US$17.1m0.68%0.01%
0.99%
GMT Capital Corp.
891,836US$16.2m-5.44%0.48%
0.97%
Deerfield Management Company, L.P. Series C
869,250US$15.8m30.3%0.24%
0.91%
Michael Davidson
818,563US$14.9m0.61%no data
0.89%
Artal Group S.A.
800,000US$14.6m0%0.34%
0.76%
Pictet Asset Management Limited
683,681US$12.5m5.22%0.01%
0.62%
Avidity Partners Management, L.P.
559,300US$10.2m17.8%0.4%
0.54%
Woodline Partners LP
483,388US$8.8m0%0.08%
0.48%
BioGeneration Ventures B.V.
427,831US$7.8m0%100.0%
0.47%
Affinity Asset Advisors, LLC
423,155US$7.7m47.9%1.25%
0.44%
Decheng Capital LLC
400,000US$7.3m0%1.99%